1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow David Rizzieri: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| EL625 in Persistent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma cenersen sodium, Rituximab, Cyclophosphamide - Lymphoma, Small Lymphocytic, Leukemia, Lymphocytic, Chronic | Phase 2 | Terminated | David Rizzieri | 20 | 2008-02-01 | 2012-11-28 |
Leukemia, Lymphocytic, Chronic, B-Cell (1)
Cyclophosphamide (1) · Rituximab (1) · fludarabine (1) · fludarabine phosphate (1)
United States (1)